
Triple-agonist research peptide
Retatrutide 20mg3mL vial
Retatrutide is a synthetic peptide studied in laboratory models as a triple receptor agonist (GLP-1, GIP and glucagon). Supplied as a lyophilised powder in a sealed glass vial for in-vitro reconstitution and analytical work only.
- Metabolic signalling pathway studies
- Receptor binding and agonist assays
- Comparative in-vitro peptide research
$120AUD
Full details





